Ipilimumab/nivolumab/pembrolizumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2030卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69043-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：242 / 242

相关论文

共 50 条

[1] Ipilimumab/nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2041 (1) : 200 - 200
[2] Ipilimumab/nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1907 (1) : 270 - 270
[3] Ipilimumab/nivolumab/pembrolizumabLack of efficacy and pain: case report
Reactions Weekly, 2023, 1943 (1) : 371 - 371
[4] Ipilimumab/nivolumab/pembrolizumabLack of efficacy, hepatitis and hepatitis relapse: case report
Reactions Weekly, 2023, 1975 (1) : 200 - 200
[5] Ipilimumab/nivolumab/pembrolizumabLack of efficacy, uveitis and skin rash: case report
Reactions Weekly, 2023, 1946 (1) : 307 - 307
[6] Ipilimumab/nivolumab/pembrolizumabLack of efficacy: 16 case reports
Reactions Weekly, 2023, 1955 (1) : 213 - 213
[7] Ipilimumab/nivolumab/pembrolizumabLack of efficacy and colitis
Reactions Weekly, 2024, 2005 (1) : 470 - 470
[8] Nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 759 - 759
[9] Nivolumab/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1935 (1) : 347 - 347
[10] Ipilimumab/pembrolizumabLack of efficacy and liver toxicity: case report
Reactions Weekly, 2023, 1968 (1) : 184 - 184

← 1 2 3 4 5 →